Results 1 to 10 of about 30,268 (254)

Acute Transverse Myelitis Following COVID-19 Vaccination [PDF]

open access: yesVaccines, 2021
An increasing number of people are undergoing vaccination for COVID-19 because of the ongoing pandemic. The newly developed, genetically engineered mRNA vaccines are critical for controlling the epidemic disease. However, major adverse effects, including
Jhih-Jian Gao   +5 more
doaj   +6 more sources

Acute Transverse Myelitis after COVID-19 Vaccination [PDF]

open access: yesMedicina, 2021
The adverse effects of the COVID-19 vaccine have been discovered as the rapid application of the vaccines continues. Neurological complications such as transverse myelitis raise concerns as cases were observed in clinical trials. Transverse myelitis is a
Yu-Ting Hsiao   +3 more
doaj   +3 more sources

Physiotherapy management of acute transverse myelitis in a pediatric patient in a Nigerian hospital: a case report [PDF]

open access: yesJournal of Medical Case Reports, 2022
Background Transverse myelitis is a rare neurological disorder of the spinal cord, caused by inflammation and damage of the myelin sheath of the neurons of the spinal cord across one or more spinal segments.
Chukwuebuka P. Onyekere   +1 more
doaj   +3 more sources

Early SARS-CoV-2-associated acute transverse myelitis: A case for neurotropism? [PDF]

open access: yesJ Intern Med, 2022
There are increasing reports of immune‐mediated and para‐infectious syndromes beyond the well‐known respiratory manifestations of severe‐acute‐respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
Lu IF   +5 more
europepmc   +2 more sources

Acute transverse myelitis progressing to permanent quadriplegia following COVID-19 infection. [PDF]

open access: yesAm J Emerg Med, 2022
As of January 2022, there have been over 350 million confirmed cases of COVID-19 in the world. The most common symptoms in those infected are fever, cough, malaise, and myalgia, however pulmonary, hematologic, gastrointestinal, renal, and neurologic ...
Prete S   +3 more
europepmc   +2 more sources

Case Reports of Acute Transverse Myelitis Associated With mRNA Vaccine for COVID-19. [PDF]

open access: yesJ Korean Med Sci, 2022
Acute transverse myelitis (ATM) has been reported as rare complication of vaccination. Herein, we report 2 cases of ATM after the administration of an mRNA vaccine for coronavirus disease 2019 (COVID-19).
Eom H   +6 more
europepmc   +2 more sources

Systemic Lupus Erythematosus and Acute Transverse Myelitis: An Unusual Association—A Case Report [PDF]

open access: yesCase Reports in Medicine
Acute transverse myelitis is a rare neurological complication of systemic lupus erythematosus (SLE), particularly in sub-Saharan African origin patients. We report a case of acute transverse myelitis in a sub-Saharan African origin patient with SLE. This
Baowêndsôm Armelle Djamilatou Sawadogo   +6 more
doaj   +2 more sources

Rare case of acute transverse myelitis associated with Lyme neuroborreliosis [PDF]

open access: yesIDCases, 2022
Acute transverse myelitis is a neurological disorder that leads to acute spinal cord injury due to inflammation caused by autoimmune disorders or by parainfectious etiologies.
Mujtaba Chohan, Dhara Rana, Nagwa Hafez
doaj   +2 more sources

A Case of Acute Transverse Myelitis in a Mildly Symptomatic Patient: An Emerging and Serious Neurological Manifestation of COVID-19. [PDF]

open access: yesCureus, 2022
Coronavirus disease 2019 (COVID-19) is known to have neurological manifestations and one of them is acute transverse myelitis (ATM). Despite being exceedingly rare (1.34-4.6 cases per million/year), COVID-19-associated ATM cases have continuously been ...
Lingas EC.
europepmc   +2 more sources

Neuroimmunology and Novel Methods of Treatment for Acute Transverse Myelitis. [PDF]

open access: yesCureus, 2021
Acute transverse myelitis (ATM) is a rare, immune-mediated pathology that is defined as an adverse inflammatory response in the spinal cord leading to neurologic injury. The pathophysiology of ATM is poorly understood, with no apparent differences in age,
Fiani B, Covarrubias C, Jarrah R.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy